retinoids - CISMeF

Preferred Label : retinoids;

MeSH definition : A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.;

MeSH synonym : Retinoid;

Wikipedia link : https://en.wikipedia.org/wiki/Retinoid;

Is substance : O;

Details

Origin ID

D012176;

UMLS CUI

C0035339;

ATC code(s)
- Retinoids for cancer treatment [ATC Code]
ATC code(s)
- Retinoids for cancer treatment [ATC Code]
- retinoids for topical use in acne [ATC Code]
- retinoids for treatment of acne [ATC Code]
- retinoids for treatment of psoriasis [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Retinoids [ICD-11 Extension code]
Currated CISMeF NLP mapping
- Product containing retinoid (product) [SNOMED CT concept]
- Retinoic Acid Agent [NCIt concept]
- Retinoid [NCIt concept]
- Retinoid (substance) [SNOMED CT concept]
- retinoids [IUPAC Term]
Indexing information
- 14-hydroxy-4,14-retro-retinol [MeSH Supplementary Concept]
- 4-(2-(5,6,7,8--tetrahydro-5,5,8,8-tetramethylquinoxalyl)carboxamido)benzoic acid [MeSH Supplementary Concept]
- 4-(3-methyl-5-(2',6',6'-trimethyl-1'-cyclohex-1'-yl)pentadienamido)benzoic acid [MeSH Supplementary Concept]
- 4-(5-(7-fluoro-4-(trifluoromethyl)benzo(b)furan-2-yl)-1H-2-pyrrolyl)benzoic acid [MeSH Supplementary Concept]
- 4-(acetylamino)phenylretinoate [MeSH Supplementary Concept]
- 4-hydroxy-retinol [MeSH Supplementary Concept]
- 6-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-1,4-disilanaphthalen-6-yl)-2-naphthoic acid [MeSH Supplementary Concept]
- AGN 190299 [MeSH Supplementary Concept]
- CD 2019 [MeSH Supplementary Concept]
- CD 2409 [MeSH Supplementary Concept]
- LE 135 [MeSH Supplementary Concept]
- LE 540 [MeSH Supplementary Concept]
- LE 550 [MeSH Supplementary Concept]
- MX 781 [MeSH Supplementary Concept]
- am 580 [MeSH Supplementary Concept]
- ethyl 4-(2-(3,4-dihydro-4,4-dimethyl-2H-1 benzopyran-6-yl)-1-propenyl)benzoate [MeSH Supplementary Concept]
- re 80 [MeSH Supplementary Concept]
- ro 41-5253 [MeSH Supplementary Concept]
- ro 46-5471 [MeSH Supplementary Concept]
- ro 46-8515 [MeSH Supplementary Concept]
- tazarotene [MeSH Supplementary Concept]
Record concept(s)
- retinoids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid [MeSH Supplementary Concept]
- (S)-N-retinylidene-alpha-(1-naphthyl)ethylamine [MeSH Supplementary Concept]
- 3',5'-ditertiary-butiary-4'-methoxycarboxylchalcone [MeSH Supplementary Concept]
- 3-azido-4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propen-1-yl)benzoic acid [MeSH Supplementary Concept]
- 3-hydroxyretinoic acid [MeSH Supplementary Concept]
- 4-(1-methyl-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-(propenylidene)-2-cyclohepten-1-ylidene)ethanol [MeSH Supplementary Concept]
- 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid [MeSH Supplementary Concept]
- 4-(3-(2,6,6-trimethyl-1-methyl-1-cyclohexen-1-yl)-2-(propenylidene)-2-cyclohepten-1-ylidene)acetaldehyde [MeSH Supplementary Concept]
- 4-(4-azido-5,6,7,8-tetrahydro-1,5,5,8,8-pentamethyl-2-anthracenyl)benzoic acid [MeSH Supplementary Concept]
- 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid [MeSH Supplementary Concept]
- 4-acetamidophenyl retinoate [MeSH Supplementary Concept]
- 4-amino-2-(butyrylamino)phenyl(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoate [MeSH Supplementary Concept]
- 4-amino-2-trifluoromethyl-phenyl retinate [MeSH Supplementary Concept]
- 5-methyl-7-(2,6-dimethyl-6-ethoxycarbonyl-3-oxo-1-cyclohexyl)-2,4,6-heptatrienoic acid [MeSH Supplementary Concept]
- 6-(5-azido-5,6,7,8-tetrahydro-5,8,8-trimethyl-2-naphthalenyl)-2-naphthalenecarboxylic acid [MeSH Supplementary Concept]
- 6-(5-azido-5,6,7,8-tetrahydro-8,8-dimethyl-2-naphthalenyl)-2-naphthalenecarboxylic acid [MeSH Supplementary Concept]
- 7-(2,2,6-trimethylcyclohexen-1-yl)-5-methyl-2,4,6-heptatrienal [MeSH Supplementary Concept]
- A2-E (N-retinylidene-N-retinylethanolamine) [MeSH Supplementary Concept]
- A2-PE compound [MeSH Supplementary Concept]
- A2-rhodopsin [MeSH Supplementary Concept]
- ADAM 3 [MeSH Supplementary Concept]
- AGN 190727 [MeSH Supplementary Concept]
- AGN 195183 [MeSH Supplementary Concept]
- ALRT 1550 [MeSH Supplementary Concept]
- BMS 189453 [MeSH Supplementary Concept]
- BMS 649 [MeSH Supplementary Concept]
- BMS 961 [MeSH Supplementary Concept]
- BMS453 [MeSH Supplementary Concept]
- C22 aldehyde [MeSH Supplementary Concept]
- CD 2394 [MeSH Supplementary Concept]
- CD 2608 [MeSH Supplementary Concept]
- CD 394 [MeSH Supplementary Concept]
- CD 437 [MeSH Supplementary Concept]
- CD 666 [MeSH Supplementary Concept]
- KYN 54 [MeSH Supplementary Concept]
- LG 100629 [MeSH Supplementary Concept]
- LG 100754 [MeSH Supplementary Concept]
- LG 100815 [MeSH Supplementary Concept]
- LG 101208 [MeSH Supplementary Concept]
- LG10068 [MeSH Supplementary Concept]
- MDI 301 [MeSH Supplementary Concept]
- MM 11254 [MeSH Supplementary Concept]
- MM 11365 [MeSH Supplementary Concept]
- MM11453 [MeSH Supplementary Concept]
- MX 781 [MeSH Supplementary Concept]
- MX 84 ester [MeSH Supplementary Concept]
- N-acetylretinylamine [MeSH Supplementary Concept]
- N-benzoylretinylamine [MeSH Supplementary Concept]
- N-retinylidene-n-butylamine [MeSH Supplementary Concept]
- N-retinylidene-phosphatidylethanolamine [MeSH Supplementary Concept]
- R 8605 [MeSH Supplementary Concept]
- R 8923 [MeSH Supplementary Concept]
- Ro 15-1570 [MeSH Supplementary Concept]
- Ro48 2250 [MeSH Supplementary Concept]
- SMR 2 [MeSH Supplementary Concept]
- SMR 6 [MeSH Supplementary Concept]
- SR 11217 [MeSH Supplementary Concept]
- SR 11235 [MeSH Supplementary Concept]
- SR 11237 [MeSH Supplementary Concept]
- SR 11238 [MeSH Supplementary Concept]
- SR 11302 [MeSH Supplementary Concept]
- acyclo-retinoic acid [MeSH Supplementary Concept]
- acycloretinal [MeSH Supplementary Concept]
- adarotene [MeSH Supplementary Concept]
- arotinoic methanol [MeSH Supplementary Concept]
- benzochromenyl retinoid [MeSH Supplementary Concept]
- benzothiochromenyl retinoid [MeSH Supplementary Concept]
- dihydroanthracenyl retinoid [MeSH Supplementary Concept]
- ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid [MeSH Supplementary Concept]
- hydroxenin monoacetate [MeSH Supplementary Concept]
- iisoA2E [MeSH Supplementary Concept]
- methylarotinoid [MeSH Supplementary Concept]
- mofarotene [MeSH Supplementary Concept]
- pdA2E compound [MeSH Supplementary Concept]
- retinamidobenzyl glucuronide [MeSH Supplementary Concept]
- retinyl ascorbate [MeSH Supplementary Concept]
- retinyl retinoate [MeSH Supplementary Concept]
- retinylidene chromophore [MeSH Supplementary Concept]
- retinylidene dimedone [MeSH Supplementary Concept]
- retinylidene methylnitrone [MeSH Supplementary Concept]
- ro 14-6113 [MeSH Supplementary Concept]
- ro 16-9100 [MeSH Supplementary Concept]
- ro 23-9223 [MeSH Supplementary Concept]
- tauret [MeSH Supplementary Concept]
- temarotene [MeSH Supplementary Concept]
- trifarotene [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing retinoid (product) [SNOMED CT concept]
- Retinoic Acid Agent [NCIt concept]
- Retinoid [NCIt concept]
- Retinoid (substance) [SNOMED CT concept]
- retinoids [IUPAC Term]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients